Remove Certification Remove Circulation Remove Heart Failure
article thumbnail

FAQs about the Cardiology Recertification Exam

BoardVitals - Cardiovascular

The Cardiovascular Disease Maintenance of Certification Exam can be difficult, with a pass rate in 2021 of 88%. In early 2022, the ABIM updated its fee structure to help physicians pay less over time to maintain their certifications. What are some things you need to know before you sit for the exam? How much does the exam cost?

article thumbnail

5 Free Cardiology MOC Practice Questions

BoardVitals - Cardiovascular

This certification is known to be one of the harder ones, with a pass rate of 88% in 2021 , so don’t procrastinate studying. Heart Failure and Cardiomyopathy 19% Valvular Disease 15% Pericardial Disease 3% Congenital Heart Disease 3% Vascular Diseases 5% Systemic Hypertension and Hypotension 8.5%

article thumbnail

Mavacamten: Real-World Experience from 22 Months of the Risk Evaluation and Mitigation Strategy (REMS) Program

Circulation: Heart Failure

Circulation: Heart Failure, Ahead of Print. Background:Mavacamten is the only cardiac myosin inhibitor approved by the US FDA for treatment of symptomatic New York Heart Association class II-III obstructive hypertrophic cardiomyopathy (HCM) patients. were women; 64.6% were >60 years of age. were women; 64.6%

article thumbnail

Abstract 4145840: Hypertensive Cardiorenal Disease with Cardiorenal Failure vs. Hypertensive Renal Disease with Renal Failure: Racial Mortality Trends from 1999 to 2020 in the United States

Circulation

Circulation, Volume 150, Issue Suppl_1 , Page A4145840-A4145840, November 12, 2024. Temporal trends were examined using the average annual percent change (AAPC) determined by joinpoint regression.Result:From 1999 to 2020, a total of 100,705 people died from hypertensive heart and renal disease in the USA. The overall AAMR of 1.4